Hydralazine and Valproate Added to Chemotherapy for Breast Cancer

This study has been terminated.
Sponsor:
Collaborators:
National Council of Science and Technology, Mexico
Psicofarma S.A. de C.V.
Information provided by:
National Institute of Cancerología
ClinicalTrials.gov Identifier:
NCT00395655
First received: November 1, 2006
Last updated: NA
Last verified: November 2006
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: August 2006
  Estimated Primary Completion Date: No date given